Follow the Pundits

Tag: Cathie Wood

Illustration of a roller coaster shaped like a stock chart labeled “ARKK,” with symbols of AI, biotech, Tesla, and crypto, representing the volatility and comeback of Cathie Wood’s innovation fund.

ARKK 2025: The “Mojo” Is Back (But the Volatility Never Left)

ARKK crushed 2025, face-planted in early 2026, and reminded everyone why Cathie Wood’s fund is the wildest ride in innovation investing. Fun, data-driven, and brutally honest about the volatility.

Read entire article

Tags: #FoodieInParis, AI Investing, AMD, Ark Invest, ARKK, ARKK Fund, ARKK stocks, Biotech, Biotech Innovation, Biotech Investing, Biotech Investments, Biotech Picks, Biotech Stocks, BiotechGrowth, BiotechInvesting, Biotechnology Innovation, Cathie Wood, Cathie Wood Stocks, Coinbase, CRISPR Therapeutics, CRSP, Crypto Stocks, featured-hedge-funds, FUNanc1al, FUNanc1al Edge, FUNanc1al Investing, Funds, Growth Investing, hub-hedge, Innovation ETFs, Portfolio Strategy, Robinhood, Roku, SHOP, Shopify, Tech Stocks, TEM, Tempus AI, Tesla, TSLA, Volatility
Modern editorial illustration of CRISPR gene editing: a DNA helix morphs into a stock chart, with lab and Wall Street symbols representing breakthrough biotech potential and high volatility risk.

Revisiting The Case of CRISPR Therapeutics: Still Crisp, Still Risky, Still Dangerously Alluring

CRISPR Therapeutics (CRSP) has the first widely approved CRISPR-based therapy, huge insider buying near today’s price, and institutions (including ARK) deep in the name — while shorts pile on. Crisp setup, risky execution, dangerously alluring upside. 🧬🎯

Read entire article

Tags: ARKG, ARKK, ARKK Fund, ARKK stocks, Biotech, Biotech Humor, Biotech Innovation, Biotech Investing, biotech jokes, Biotech Picks, Buy or sell CRSP, CASGEVY, Cathie Wood, Cathie Wood Stocks, CRISPR Therapeutics, CRSP, featured-hedge-funds, funanc1al edge, funanc1al humor, funanc1al investing, FUNstock Index, Gene Editing, Growth Stocks, High Risk High Reward, hub-hedge, hub-insiders, Insider Purchases, risks buying crsp, Short Interest, why buy crsp
A robotic arm reaches toward a glowing semiconductor chip with dollar signs floating around it—captioned: 'Cathie Wood Buys More Teradyne (TER)' with Funanc1al’s logo and emoji icons for humor.

Cathie Wood’s Ark Bought More Teradyne (TER)… Should You?

Cathie Wood is doubling down on Teradyne, a robotics and semiconductor test powerhouse with a $1B buyback plan and big AI dreams. Should investors follow? Our fun, fact-filled breakdown has you covered.

Read entire article

Tags: AI Stocks, Ark Invest, Cathie Wood, Finance with Fun, Funanc1al, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alInsights, Funanc1alInvesting, Funanc1alNews, FunFacts, FunFinance, Hedge Fund Bets, Hedge Funds Investing, HedgeFundBuys, Institutional Buying, Investing with a Twist, Investor Behavior, Robotics, Semiconductor Test, Share Buybacks, Stock Market Humor, Stock Market Trends 2025, Stocks & Fun, Tech Stocks, TER Stock, Teradyne, Wall Street Trends